Your session is about to expire
← Back to Search
SULT Allosteric Inhibition for Metabolic Side Effects
Study Summary
This trial will test whether the NSAID mefenamic acid can inhibit the sulfonation of the specific substrate acetaminophen in humans, and whether this effect is specific to SULT1A1 or whether it is also seen with SULT2A1.
- Metabolic Side Effects
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are individuals aged 50 or over permitted to participate in this experiment?
"Patients aged 61 to 65 are eligible for participation in this trial, while those younger than 18 and older than 65 have access to 8 and 40 trials respectively."
What eligibility criteria must be fulfilled to join this experimental trial?
"This research is accepting one individual, aged 61 years old, who displays metabolic side effects of medications as a participant. Moreover, the candidate must meet all other criteria listed in the inclusion requirements."
Does this trial currently have available spots for participants?
"The trial listed on clinicaltrials.gov is not actively enrolling patients, with the first posting being made in November 2018 and most recent update occurring in April 2022. Fortunately, there are 44 other trials presently recruiting candidates for participation."
Share this study with friends
Copy Link
Messenger